Research & Development: Page 80
-
PharmaVoice Team/PharmaVoice
Early Research
RESEARCH & Development Early Research The Future of innovation Discovery and research technologies are advancing and will have a tremendous impact on the pipelines of the future. BY DENISE MYSHKO The way new medicines are discovered is on the cusp of revolutionary change. Advances in the unde...
By Denise Myshko • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
At A Glance
Looking Forward At a GLANCE This special Year in Preview issue provides insights into the trends that will impact the industry in the coming year and beyond. Below are some highlights from the sectors covered in the following pages. Focus on specialty markets David Avitabile President JFK Communi...
By PharmaVoice Team • Nov. 22, 2008 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Barry Goldstein Merck Appoints Head of Diabetes, Obesity Development Global pharmaceutical company Merck, Whitehouse Station, N.J., has named Barry Goldstein, M.D., Ph.D., FACP, FACE, VP of diabetes and obesity clinical development. In addition to leading overall development of co...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
CONSUMER PERSPECTIVE Consumers Wary of Therapeutic Switches Almost three quarters of prescription drug users would be very concerned if a drug they were prescribed was switched to another drug designed to treat the same condition without their doctor’s knowledge, according to a survey released by...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
eClinical Meets eLearning - Integrated eLearning Enables Efficient
16 October 2008 VIEW on ESolutions ECLINICAL Multifunction eClinical systems are becoming the norm for capturing and managing data in clinical trials. Unfortunately, the training of site staff to use these systems is still taking place in one on one sessions or at investigator meetings. The use o...
By PharmaVoice Team • Oct. 24, 2008 -
PharmaVoice Team/PharmaVoice
Where eClinical Meets Business Process
14 October 2008 VIEW on ESolutions ECLINICAL Early electronic data capture focused on finding efficiencies in data management activities, such as data entry and cleaning. When eClinical hit the mainstream, it delivered a clear view of complete trial data on a realtime basis, enabling clinical tri...
By PharmaVoice Team • Oct. 24, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
4 October 2008 VIEW on ESolutions TABLE OF CONTENTS Letter from the Editor The Forum Hitting a MobileTarget: New technologies, such as social networking and wireless mobile applications, have the potential to connect pharma with consumers, patients, and physicians more quickly and effectively tha...
By PharmaVoice Team • Oct. 24, 2008 -
PharmaVoice Team/PharmaVoice
Joe Jimenez: Straightforward and Consumer Focused
BY KIM RIBBINK COMPLETE The Package With an ability to step back from the protracted machinations that often prevail at pharma companies, is leading Novartis with a focus on the customer and a commitment to meeting goals and priorities. JOE Jimenez Sometimes it’s the simplest observations that he...
By Kim Ribbink • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
Life After the Focus Group
BY ROBIN ROBINSON IS THE FOCUS GROUP DEAD OR JUST DECLINING? While some people say the focus group is dead, others say it will never entirely disappear. Their opinions hinge on what position they hold in the market research process and what objective the research is trying to meet (turn to page 3...
By Robin Robinson • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
October 15 3rd Leadership Summit on Medicare Enrollment and PDE Data Reconciliation Hilton Old Town, Alexandria, Va. PharmaVOICE subscribers receive $300 discount; register using keycode HYU957. For more information, contact Jodi Bova, Center for Business Intelligence, at 781-939-2563, email jodi...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES inVentiv Health has relaunched The Rx Law Book, an online library that provides pharmaceutical companies with convenient, centralized access to comprehensive state and federal regulatory information pertaining to product marketing...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTH CARE RELATED PRODUCTS, SERVICES, AND COMPANIES Julie Kampf has launched Career Central, a consulting firm that provides executive skill building to job seekers ranging from recent college graduates to senior level managers to professionals seeking a second or third career. Career Centr...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Cubist Pharmaceuticals’ Cubicin (daptomycin), the first of the cyclic lipopeptides to gain U.S.market approval, is currently the fastest growing product in the antibiotic class, with 2007 sales surging 53% to $290.4 million. The first oxazolidinone to win U.S.Food and Drug Administration approval...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
Michael Pucci — The Man, The Mission, The Message
BY TAREN GROM He started as one man with a mission five years ago. Today Michael Pucci is inspiring legions as one of the industry’s staunchest advocates as he strives to improve the image of pharma with a message based on science and solid data. MAN THE MISSION THE MESSAGE THE PV0908LayoutFINAL ...
By Taren Grom • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
The Green Movement: Rethinking Chemistry
BY DENISE MYSHKO Major pharmaceutical companies are working together to minimize the environmental impact of how they make their products. The GREEN MOVEMENT Rethinking Chemistry GREEN IS THE NEW BLACK. The push to make prescription drugs more efficient, cleaner, and safer is gaining momentum ami...
By Denise Myshko • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
4th Integrating Electronic Health Records and eClinical Technologies Conference Baltimore Marriott Waterfront Hotel,Baltimore For more information, contact Jasmaine John, ExL Pharma,at 2124006235, email [email protected], or visit exlpharma.com. September 1516 Biotech Patents Royal Sonesta Hote...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
MARKET BUSTERS Global Drug Market to Exceed $1 Trillion According to a new market research report from BCC Research, the global market for pharmaceuticals is expected to reach more than $1.0 trillion in 2013. The 2008 estimated market value is $737.6 billion. The market is broken down into brande...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE PharmaVOICE 100 THE FORUM FOR THE INDUSTRY EXECUTIVE July/August 2008 SPECIAL ISSUE 100 of the Most Inspiring People www.pharmavoice.com Download PDF
By PharmaVoice Team • July 28, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PharmaVOICE is delighted to publish the fourth annual special issue featuring 100 of the most inspiring individuals in the life-sciences industry. This issue has become one of my favorites and, from all accounts, one of yours as well. What’s not to love? This issue celebrates the men and women of...
By Taren Grom • July 27, 2008 -
PharmaVoice Team/PharmaVoice
The Mentors
Brian Corvino Mary Lacquaniti Lelia O’Connor Danita Sutton, Ph.D. MENTORING AND SHAPING THE CAREERS OF OTHERS ARE VENERABLE AND ADMIRABLE TALENTS. MENTORING TAKES PATIENCE, FORESIGHT, AND UNSELFISH DEVOTIONTO OTHERS’ SUCCESS and is a skill that is often unheralded — until now. We salute those who...
By PharmaVoice Team • July 24, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
Valdo Arnera, M.D. Bill Byrom, Ph.D. Philip A. Garland Keith Howells Don Schenker Rodney Spady A creative and passionate approach to pioneering new areas of technology applications and new products has enabled Dr. Bill Byrom to engender real improvements in the drug development process. For the p...
By PharmaVoice Team • July 24, 2008 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
The PATIENT ADVOCATES Jon Butko Jaime Cohen Steven V. Edelman, M.D. Linda Kitlinski Kristin Patton Dorothy Smith, Pharm.D. Joseph Tonning, M.D., M.P.H., R.Ph. Meg Walsh Jeanne Zucker The Patient Advocates PATIENT CENTRIC IS AN UNDERSTATEMENT WHEN DESCRIBING THESE INDUSTRY LEADERS. THEY TAKE THEIR...
By PharmaVoice Team • July 24, 2008 -
PharmaVoice Team/PharmaVoice
Intensive QT Trials — "The Not-So-Thorough QT Study"
38 June 20 08 VIEW on Clinical Operations QT TRIALS T he ICH E14 gives guidance regarding the conduct of socalled “Thorough QT Trials (TQT).” While discussions around this guidance occurred well before the final adoption of the doc ument, little was said about classes of drugs where a classic TQT...
By PharmaVoice Team • June 9, 2008 -
PharmaVoice Team/PharmaVoice
Evaluating and Allocating Advertising Budgets: A Sponsor's Responsibility
36 June 20 08 VIEW on Clinical Operations PATIENT RECRUITMENT E valuating and allocating costefficient, yet costeffective advertising bud gets for a patient recruiting campaign is an issue that rarely receives the attention it deserves. A wellplanned budget is absolutely integral to the success o...
By PharmaVoice Team • June 9, 2008 -
PharmaVoice Team/PharmaVoice
Direct-to-Patient Advertising Enhances Study Recruitment
34 June 20 08 VIEW on Clinical Operations PATIENT RECRUITMENT re the needed patients available at the investigator sites? Answer ing this question incorrectly means that the clinical trial will fall short of its goal, and most trials run late due to patient enroll ment issues.The following case s...
By PharmaVoice Team • June 9, 2008
Previous
